CHC Health has announced a strategic partnership with Catalyst Healthcare, an award-winning technology company, and Pack4U for delivery of connected care at home, to provide virtual pharmacist services for improving medication adherence and patient health outcomes. Read More »

Adding Drug Collection Units in 29 CVS Pharmacy Locations Across the State Read More »

Bryn's Epinephrine Nasal Spray has Two Doses in One Portable Device Read More »

Ademi & O'Reilly, LLP is investigating Achillion (NASDAQ:ACHN) for possible breaches of fiduciary duty and other violations of the law in connection with the sale of Achillion to Alexion. Read More »

Acquisition bolsters Eyevance's position as an emerging leader in treating anterior segment and ocular surface conditions Read More »

Florida-based SMP Pharmacy Solutions announces strategic acquisition of Northridge Plaza Pharmacy to serve growing demand in California fertility market Read More »

A Trifecta of Relief Formulated with HydroCell™ Technology Offers New Artificial Tear Options for Patients Suffering from Eye Dryness Read More »

MedicaSafe will combine the generic version of Suboxone® (buprenorphine and naloxone) with its smart medication systems to treat opioid dependence Read More »

PANTHERx is excited to announce that it is the first pharmacy nationwide that has been awarded the Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). Read More »

Acquisition is expected to realize over $10M in annual synergies Read More »

TWILIGHT Study Fails to Answer Key Scientific Question Regarding Most Efficacious Treatment Post-PCI Read More »

Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potential treatment of Stage IIb-IV melanoma. Read More »

Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will participate in the Oppenheimer & Co. Fall Summit Focused on Specialty Pharma, Rare Disease & Gene Therapy, being held September 23-24, 2019 in New York City. Read More »

New Board Members Also Announced, Including Representatives from AstraZeneca, UCB, and US Bioservices2019-2020 NASP President-Elect Announced Read More »

Grane Rx--the leading provider of senior care pharmacy solutions--proudly celebrates 25 years in business this month. Grane Rx opened its doors in 1994 to serve Pennsylvanians and today serves more than 11,500 residents and participants across 70+ facilities nationwide. Read More »

CTP-543 Achieved its Primary Endpoint in the 8 mg and 12 mg Twice-Daily Dosing Cohorts Read More »

Collaboration combines strengths to develop and commercialize life-saving antifungal treatment and prophylaxis, an area of high unmet medical need Read More »

Former Publix Super Markets Pharmacy Executive joins company as it expands its 3D-printed product portfolio Read More »

Court rules in favor of Regeneron and Sanofi in ongoing Praluent® (alirocumab) patent litigation Read More »

Study Evaluated Efficacy and Safety of ABP 798 Compared to Rituxan in Patients With Non-Hodgkin's Lymphoma Read More »